APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hog Cholera Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hog Cholera Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchHog Cholera Vaccine Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Hog Cholera Vaccine Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Hog Cholera Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hog Cholera Vaccine Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Hog Cholera Vaccine Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Hog Cholera Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hog Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hog Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hog Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hog Cholera Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hog Cholera Vaccine include WINSUN, Agrovet, Bioveta, Boehringer Ingelheim, CAHIC, CAVAC, Ceva, Chopper Biology and DHN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hog Cholera Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hog Cholera Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hog Cholera Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hog Cholera Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Hog Cholera Vaccine Segment by Company

WINSUN

Agrovet

Bioveta

Boehringer Ingelheim

CAHIC

CAVAC

Ceva

Chopper Biology

DHN

Institutul Pasteur

Komipharm

MSD Animal Health (Merck)

MVP

Ringpu Biology

Tecon

ChengDu Tecbond

Jinyu Bio-Technology

Qilu Animal Health Products Factory

Harbin Veterinary Research Institute

Hog Cholera Vaccine Segment by Type

Tissue Culture Origin

Cell Line Origin

Hog Cholera Vaccine Segment by Application

Government Tender

Market Sales

Hog Cholera Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hog Cholera Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hog Cholera Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hog Cholera Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hog Cholera Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hog Cholera Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hog Cholera Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hog Cholera Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hog Cholera Vaccine Industry Trends Table 2. Hog Cholera Vaccine Industry Drivers Table 3. Hog Cholera Vaccine Industry Opportunities and Challenges Table 4. Hog Cholera Vaccine Industry Restraints Table 5. Global Hog Cholera Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hog Cholera Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hog Cholera Vaccine Sales by Manufacturers (m units) & (2021-2026) Table 8. Global Hog Cholera Vaccine Sales Market Share by Manufacturers Table 9. Global Hog Cholera Vaccine Average Sales Price (US$/k unit) of Manufacturers (2021-2026) Table 10. Global Hog Cholera Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hog Cholera Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hog Cholera Vaccine Manufacturers, Product Type & Application Table 13. Global Hog Cholera Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hog Cholera Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tissue Culture Origin Table 17. Major Manufacturers of Cell Line Origin Table 18. Global Hog Cholera Vaccine Sales by Type 2021 VS 2025 VS 2032 (m units) Table 19. Global Hog Cholera Vaccine Sales by Type (2021-2026) & (m units) Table 20. Global Hog Cholera Vaccine Sales by Type (2027-2032) & (m units) Table 21. Global Hog Cholera Vaccine Sales Market Share by Type (2021-2026) Table 22. Global Hog Cholera Vaccine Sales Market Share by Type (2027-2032) Table 23. Global Hog Cholera Vaccine Revenue by Type 2021 VS 2025 VS 2032 (m units) Table 24. Global Hog Cholera Vaccine Revenue by Type (2021-2026) & (m units) Table 25. Global Hog Cholera Vaccine Revenue by Type (2027-2032) & (m units) Table 26. Global Hog Cholera Vaccine Revenue Market Share by Type (2021-2026) Table 27. Global Hog Cholera Vaccine Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Government Tender Table 29. Major Manufacturers of Market Sales Table 30. Global Hog Cholera Vaccine Sales by Application 2021 VS 2025 VS 2032 (m units) Table 31. Global Hog Cholera Vaccine Sales by Application (2021-2026) & (m units) Table 32. Global Hog Cholera Vaccine Sales by Application (2027-2032) & (m units) Table 33. Global Hog Cholera Vaccine Sales Market Share by Application (2021-2026) Table 34. Global Hog Cholera Vaccine Sales Market Share by Application (2027-2032) Table 35. Global Hog Cholera Vaccine Revenue by Application 2021 VS 2025 VS 2032 (m units) Table 36. Global Hog Cholera Vaccine Revenue by Application (2021-2026) & (m units) Table 37. Global Hog Cholera Vaccine Revenue by Application (2027-2032) & (m units) Table 38. Global Hog Cholera Vaccine Revenue Market Share by Application (2021-2026) Table 39. Global Hog Cholera Vaccine Revenue Market Share by Application (2027-2032) Table 40. Global Hog Cholera Vaccine Sales by Region: 2021 VS 2025 VS 2032 (m units) Table 41. Global Hog Cholera Vaccine Sales by Region (2021-2026) & (m units) Table 42. Global Hog Cholera Vaccine Sales Market Share by Region (2021-2026) Table 43. Global Hog Cholera Vaccine Sales Forecasted by Region (2027-2032) & (m units) Table 44. Global Hog Cholera Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Hog Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 46. North America Hog Cholera Vaccine Sales by Country (2021-2026) & (m units) Table 47. North America Hog Cholera Vaccine Sales by Country (2027-2032) & (m units) Table 48. Europe Hog Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 49. Europe Hog Cholera Vaccine Sales by Country (2021-2026) & (m units) Table 50. Europe Hog Cholera Vaccine Sales by Country (2027-2032) & (m units) Table 51. Asia Pacific Hog Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 52. Asia Pacific Hog Cholera Vaccine Sales by Country (2021-2026) & (m units) Table 53. Asia Pacific Hog Cholera Vaccine Sales by Country (2027-2032) & (m units) Table 54. South America, Middle East and Africa Hog Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (m units) Table 55. South America, Middle East and Africa Hog Cholera Vaccine Sales by Country (2021-2026) & (m units) Table 56. South America, Middle East and Africa Hog Cholera Vaccine Sales by Country (2027-2032) & (m units) Table 57. Global Hog Cholera Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hog Cholera Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Hog Cholera Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Hog Cholera Vaccine Revenue Market Share by Region (2021-2026) Table 61. Global Hog Cholera Vaccine Revenue Market Share by Region (2027-2032) Table 62. WINSUN Company Information Table 63. WINSUN Business Overview Table 64. WINSUN Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. WINSUN Hog Cholera Vaccine Product Portfolio Table 66. WINSUN Recent Development Table 67. Agrovet Company Information Table 68. Agrovet Business Overview Table 69. Agrovet Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Agrovet Hog Cholera Vaccine Product Portfolio Table 71. Agrovet Recent Development Table 72. Bioveta Company Information Table 73. Bioveta Business Overview Table 74. Bioveta Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Bioveta Hog Cholera Vaccine Product Portfolio Table 76. Bioveta Recent Development Table 77. Boehringer Ingelheim Company Information Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Boehringer Ingelheim Hog Cholera Vaccine Product Portfolio Table 81. Boehringer Ingelheim Recent Development Table 82. CAHIC Company Information Table 83. CAHIC Business Overview Table 84. CAHIC Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. CAHIC Hog Cholera Vaccine Product Portfolio Table 86. CAHIC Recent Development Table 87. CAVAC Company Information Table 88. CAVAC Business Overview Table 89. CAVAC Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. CAVAC Hog Cholera Vaccine Product Portfolio Table 91. CAVAC Recent Development Table 92. Ceva Company Information Table 93. Ceva Business Overview Table 94. Ceva Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Ceva Hog Cholera Vaccine Product Portfolio Table 96. Ceva Recent Development Table 97. Chopper Biology Company Information Table 98. Chopper Biology Business Overview Table 99. Chopper Biology Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Chopper Biology Hog Cholera Vaccine Product Portfolio Table 101. Chopper Biology Recent Development Table 102. DHN Company Information Table 103. DHN Business Overview Table 104. DHN Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. DHN Hog Cholera Vaccine Product Portfolio Table 106. DHN Recent Development Table 107. Institutul Pasteur Company Information Table 108. Institutul Pasteur Business Overview Table 109. Institutul Pasteur Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Institutul Pasteur Hog Cholera Vaccine Product Portfolio Table 111. Institutul Pasteur Recent Development Table 112. Komipharm Company Information Table 113. Komipharm Business Overview Table 114. Komipharm Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Komipharm Hog Cholera Vaccine Product Portfolio Table 116. Komipharm Recent Development Table 117. MSD Animal Health (Merck) Company Information Table 118. MSD Animal Health (Merck) Business Overview Table 119. MSD Animal Health (Merck) Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. MSD Animal Health (Merck) Hog Cholera Vaccine Product Portfolio Table 121. MSD Animal Health (Merck) Recent Development Table 122. MVP Company Information Table 123. MVP Business Overview Table 124. MVP Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. MVP Hog Cholera Vaccine Product Portfolio Table 126. MVP Recent Development Table 127. Ringpu Biology Company Information Table 128. Ringpu Biology Business Overview Table 129. Ringpu Biology Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Ringpu Biology Hog Cholera Vaccine Product Portfolio Table 131. Ringpu Biology Recent Development Table 132. Tecon Company Information Table 133. Tecon Business Overview Table 134. Tecon Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Tecon Hog Cholera Vaccine Product Portfolio Table 136. Tecon Recent Development Table 137. ChengDu Tecbond Company Information Table 138. ChengDu Tecbond Business Overview Table 139. ChengDu Tecbond Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. ChengDu Tecbond Hog Cholera Vaccine Product Portfolio Table 141. ChengDu Tecbond Recent Development Table 142. Jinyu Bio-Technology Company Information Table 143. Jinyu Bio-Technology Business Overview Table 144. Jinyu Bio-Technology Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Jinyu Bio-Technology Hog Cholera Vaccine Product Portfolio Table 146. Jinyu Bio-Technology Recent Development Table 147. Qilu Animal Health Products Factory Company Information Table 148. Qilu Animal Health Products Factory Business Overview Table 149. Qilu Animal Health Products Factory Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Qilu Animal Health Products Factory Hog Cholera Vaccine Product Portfolio Table 151. Qilu Animal Health Products Factory Recent Development Table 152. Harbin Veterinary Research Institute Company Information Table 153. Harbin Veterinary Research Institute Business Overview Table 154. Harbin Veterinary Research Institute Hog Cholera Vaccine Sales (m units), Price (US$/k unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Harbin Veterinary Research Institute Hog Cholera Vaccine Product Portfolio Table 156. Harbin Veterinary Research Institute Recent Development Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Hog Cholera Vaccine Distributors List Table 160. Hog Cholera Vaccine Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Hog Cholera Vaccine Product Image Figure 2. Global Hog Cholera Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hog Cholera Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Hog Cholera Vaccine Sales (2021-2032) & (m units) Figure 5. Global Hog Cholera Vaccine Average Price (US$/k unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hog Cholera Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tissue Culture Origin Image Figure 9. Cell Line Origin Image Figure 10. Global Hog Cholera Vaccine Sales by Type (2021 VS 2025 VS 2032) & (m units) Figure 11. Global Hog Cholera Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hog Cholera Vaccine Sales Market Share by Type (2021-2032) Figure 13. Global Hog Cholera Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (m units) Figure 14. Global Hog Cholera Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hog Cholera Vaccine Revenue Market Share by Type (2021-2032) Figure 16. Government Tender Image Figure 17. Market Sales Image Figure 18. Global Hog Cholera Vaccine Sales by Application (2021 VS 2025 VS 2032) & (m units) Figure 19. Global Hog Cholera Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hog Cholera Vaccine Sales Market Share by Application (2021-2032) Figure 21. Global Hog Cholera Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (m units) Figure 22. Global Hog Cholera Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hog Cholera Vaccine Revenue Market Share by Application (2021-2032) Figure 24. North America Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 25. North America Hog Cholera Vaccine Sales Market Share by Country (2021-2032) Figure 26. U.S. Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 27. Canada Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 28. Mexico Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 29. Europe Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 30. Europe Hog Cholera Vaccine Sales Market Share by Country (2021-2032) Figure 31. Germany Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 32. France Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 33. U.K. Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 34. Italy Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 35. Netherlands Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 36. Asia Pacific Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 37. Asia Pacific Hog Cholera Vaccine Sales Market Share by Country (2021-2032) Figure 38. China Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 39. Japan Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 40. South Korea Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 41. Southeast Asia Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 42. India Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 43. Australia Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 44. South America, Middle East and Africa Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 45. South America, Middle East and Africa Hog Cholera Vaccine Sales Market Share by Country (2021-2032) Figure 46. Brazil Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 47. South Africa Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 48. Saudi Arabia Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 49. Turkey Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 50. Argentina Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 51. UAE Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 52. Egypt Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 53. Chile Hog Cholera Vaccine Sales and Growth Rate (2021-2032) & (m units) Figure 54. Global Hog Cholera Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Hog Cholera Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Hog Cholera Vaccine Revenue (2021-2032) & (US$ Million) Figure 57. North America Hog Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Hog Cholera Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. Europe Hog Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Hog Cholera Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Hog Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Hog Cholera Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Hog Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Hog Cholera Vaccine Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Hog Cholera Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tissue Culture Origin
  • Cell Line Origin
Applications
  • Government Tender
  • Market Sales
Companies covered
  • WINSUN
  • Agrovet
  • Bioveta
  • Boehringer Ingelheim
  • CAHIC
  • CAVAC
  • Ceva
  • Chopper Biology
  • DHN
  • Institutul Pasteur
  • Komipharm
  • MSD Animal Health (Merck)
  • MVP
  • Ringpu Biology
  • Tecon
  • ChengDu Tecbond
  • Jinyu Bio-Technology
  • Qilu Animal Health Products Factory
  • Harbin Veterinary Research Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hog Cholera Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hog Cholera Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hog Cholera Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hog Cholera Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hog Cholera Vaccine Market Dynamics
  1. 2.1 Hog Cholera Vaccine Industry Trends
  2. 2.2 Hog Cholera Vaccine Industry Drivers
  3. 2.3 Hog Cholera Vaccine Industry Opportunities and Challenges
  4. 2.4 Hog Cholera Vaccine Industry Restraints
3 Hog Cholera Vaccine Market by Manufacturers
  1. 3.1 Global Hog Cholera Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hog Cholera Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hog Cholera Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hog Cholera Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hog Cholera Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hog Cholera Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Hog Cholera Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hog Cholera Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hog Cholera Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hog Cholera Vaccine Tier 1, Tier 2, and Tier 3
4 Hog Cholera Vaccine Market by Type
  1. 4.1 Hog Cholera Vaccine Type Introduction
  2. 4.1.1 Tissue Culture Origin
  3. 4.1.2 Cell Line Origin
  4. 4.2 Global Hog Cholera Vaccine Sales by Type
  5. 4.2.1 Global Hog Cholera Vaccine Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hog Cholera Vaccine Sales by Type (2021-2032)
  7. 4.2.3 Global Hog Cholera Vaccine Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hog Cholera Vaccine Revenue by Type
  9. 4.3.1 Global Hog Cholera Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hog Cholera Vaccine Revenue by Type (2021-2032)
  11. 4.3.3 Global Hog Cholera Vaccine Revenue Market Share by Type (2021-2032)
5 Hog Cholera Vaccine Market by Application
  1. 5.1 Hog Cholera Vaccine Application Introduction
  2. 5.1.1 Government Tender
  3. 5.1.2 Market Sales
  4. 5.2 Global Hog Cholera Vaccine Sales by Application
  5. 5.2.1 Global Hog Cholera Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hog Cholera Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Hog Cholera Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hog Cholera Vaccine Revenue by Application
  9. 5.3.1 Global Hog Cholera Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hog Cholera Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Hog Cholera Vaccine Revenue Market Share by Application (2021-2032)
6 Global Hog Cholera Vaccine Sales by Region
  1. 6.1 Global Hog Cholera Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hog Cholera Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Hog Cholera Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Hog Cholera Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hog Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hog Cholera Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hog Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hog Cholera Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hog Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hog Cholera Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hog Cholera Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hog Cholera Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hog Cholera Vaccine Revenue by Region
  1. 7.1 Global Hog Cholera Vaccine Revenue by Region
  2. 7.1.1 Global Hog Cholera Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hog Cholera Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Hog Cholera Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Hog Cholera Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hog Cholera Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Hog Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hog Cholera Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Hog Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hog Cholera Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hog Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hog Cholera Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hog Cholera Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 WINSUN
  2. 8.1.1 WINSUN Company Information
  3. 8.1.2 WINSUN Business Overview
  4. 8.1.3 WINSUN Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 WINSUN Hog Cholera Vaccine Product Portfolio
  6. 8.1.5 WINSUN Recent Developments
  7. 8.2 Agrovet
  8. 8.2.1 Agrovet Company Information
  9. 8.2.2 Agrovet Business Overview
  10. 8.2.3 Agrovet Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Agrovet Hog Cholera Vaccine Product Portfolio
  12. 8.2.5 Agrovet Recent Developments
  13. 8.3 Bioveta
  14. 8.3.1 Bioveta Company Information
  15. 8.3.2 Bioveta Business Overview
  16. 8.3.3 Bioveta Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bioveta Hog Cholera Vaccine Product Portfolio
  18. 8.3.5 Bioveta Recent Developments
  19. 8.4 Boehringer Ingelheim
  20. 8.4.1 Boehringer Ingelheim Company Information
  21. 8.4.2 Boehringer Ingelheim Business Overview
  22. 8.4.3 Boehringer Ingelheim Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boehringer Ingelheim Hog Cholera Vaccine Product Portfolio
  24. 8.4.5 Boehringer Ingelheim Recent Developments
  25. 8.5 CAHIC
  26. 8.5.1 CAHIC Company Information
  27. 8.5.2 CAHIC Business Overview
  28. 8.5.3 CAHIC Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CAHIC Hog Cholera Vaccine Product Portfolio
  30. 8.5.5 CAHIC Recent Developments
  31. 8.6 CAVAC
  32. 8.6.1 CAVAC Company Information
  33. 8.6.2 CAVAC Business Overview
  34. 8.6.3 CAVAC Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CAVAC Hog Cholera Vaccine Product Portfolio
  36. 8.6.5 CAVAC Recent Developments
  37. 8.7 Ceva
  38. 8.7.1 Ceva Company Information
  39. 8.7.2 Ceva Business Overview
  40. 8.7.3 Ceva Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ceva Hog Cholera Vaccine Product Portfolio
  42. 8.7.5 Ceva Recent Developments
  43. 8.8 Chopper Biology
  44. 8.8.1 Chopper Biology Company Information
  45. 8.8.2 Chopper Biology Business Overview
  46. 8.8.3 Chopper Biology Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chopper Biology Hog Cholera Vaccine Product Portfolio
  48. 8.8.5 Chopper Biology Recent Developments
  49. 8.9 DHN
  50. 8.9.1 DHN Company Information
  51. 8.9.2 DHN Business Overview
  52. 8.9.3 DHN Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 DHN Hog Cholera Vaccine Product Portfolio
  54. 8.9.5 DHN Recent Developments
  55. 8.10 Institutul Pasteur
  56. 8.10.1 Institutul Pasteur Company Information
  57. 8.10.2 Institutul Pasteur Business Overview
  58. 8.10.3 Institutul Pasteur Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Institutul Pasteur Hog Cholera Vaccine Product Portfolio
  60. 8.10.5 Institutul Pasteur Recent Developments
  61. 8.11 Komipharm
  62. 8.11.1 Komipharm Company Information
  63. 8.11.2 Komipharm Business Overview
  64. 8.11.3 Komipharm Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Komipharm Hog Cholera Vaccine Product Portfolio
  66. 8.11.5 Komipharm Recent Developments
  67. 8.12 MSD Animal Health (Merck)
  68. 8.12.1 MSD Animal Health (Merck) Company Information
  69. 8.12.2 MSD Animal Health (Merck) Business Overview
  70. 8.12.3 MSD Animal Health (Merck) Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 MSD Animal Health (Merck) Hog Cholera Vaccine Product Portfolio
  72. 8.12.5 MSD Animal Health (Merck) Recent Developments
  73. 8.13 MVP
  74. 8.13.1 MVP Company Information
  75. 8.13.2 MVP Business Overview
  76. 8.13.3 MVP Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MVP Hog Cholera Vaccine Product Portfolio
  78. 8.13.5 MVP Recent Developments
  79. 8.14 Ringpu Biology
  80. 8.14.1 Ringpu Biology Company Information
  81. 8.14.2 Ringpu Biology Business Overview
  82. 8.14.3 Ringpu Biology Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ringpu Biology Hog Cholera Vaccine Product Portfolio
  84. 8.14.5 Ringpu Biology Recent Developments
  85. 8.15 Tecon
  86. 8.15.1 Tecon Company Information
  87. 8.15.2 Tecon Business Overview
  88. 8.15.3 Tecon Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Tecon Hog Cholera Vaccine Product Portfolio
  90. 8.15.5 Tecon Recent Developments
  91. 8.16 ChengDu Tecbond
  92. 8.16.1 ChengDu Tecbond Company Information
  93. 8.16.2 ChengDu Tecbond Business Overview
  94. 8.16.3 ChengDu Tecbond Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 ChengDu Tecbond Hog Cholera Vaccine Product Portfolio
  96. 8.16.5 ChengDu Tecbond Recent Developments
  97. 8.17 Jinyu Bio-Technology
  98. 8.17.1 Jinyu Bio-Technology Company Information
  99. 8.17.2 Jinyu Bio-Technology Business Overview
  100. 8.17.3 Jinyu Bio-Technology Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Jinyu Bio-Technology Hog Cholera Vaccine Product Portfolio
  102. 8.17.5 Jinyu Bio-Technology Recent Developments
  103. 8.18 Qilu Animal Health Products Factory
  104. 8.18.1 Qilu Animal Health Products Factory Company Information
  105. 8.18.2 Qilu Animal Health Products Factory Business Overview
  106. 8.18.3 Qilu Animal Health Products Factory Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Qilu Animal Health Products Factory Hog Cholera Vaccine Product Portfolio
  108. 8.18.5 Qilu Animal Health Products Factory Recent Developments
  109. 8.19 Harbin Veterinary Research Institute
  110. 8.19.1 Harbin Veterinary Research Institute Company Information
  111. 8.19.2 Harbin Veterinary Research Institute Business Overview
  112. 8.19.3 Harbin Veterinary Research Institute Hog Cholera Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Harbin Veterinary Research Institute Hog Cholera Vaccine Product Portfolio
  114. 8.19.5 Harbin Veterinary Research Institute Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hog Cholera Vaccine Value Chain Analysis
  2. 9.1.1 Hog Cholera Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hog Cholera Vaccine Production Mode & Process
  6. 9.2 Hog Cholera Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hog Cholera Vaccine Distributors
  9. 9.2.3 Hog Cholera Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst